FN2 Earnings Intelligence
Stryker Corporation financials
Stryker Corporation (SYK) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $2,944 | $1,844 | $2,971 | $3,652 | $4,011 | - | - |
| + Debt | $12,479 | $13,048 | $12,995 | $13,597 | $15,859 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $17,108 | $18,449 | $20,498 | $22,595 | $25,116 | $27,284.7 | $29,674.5 |
| % Growth | 19.2% | 7.8% | 11.1% | 10.2% | 11.2% | 8.6% | 8.8% |
| Gross Profit | $10,968 | $11,578 | $13,058 | $14,440 | $16,065 | - | - |
| % Margin | 64.1% | 62.8% | 63.7% | 63.9% | 64.0% | - | - |
| EBITDA | $3,856 | $4,119 | $5,229 | $5,115 | $6,459 | - | - |
| % Margin | 22.5% | 22.3% | 25.5% | 22.6% | 25.7% | - | - |
| Net Income | $1,994 | $2,358 | $3,165 | $2,993 | $3,246 | - | - |
| % Margin | 11.7% | 12.8% | 15.4% | 13.2% | 12.9% | - | - |
| Diluted EPS | $5.21 | $6.17 | $8.25 | $7.76 | $8.40 | $15.02 | $16.75 |
| % Growth | 24.0% | 18.4% | 33.7% | -5.9% | 8.2% | 78.8% | 11.6% |
| Operating Cash Flow | $3,263 | $2,624 | $3,711 | $4,242 | $5,044 | - | - |
| CapEx | $525 | $588 | $575 | $755 | $761 | - | - |
| Free Cash Flow | $2,738 | $2,036 | $3,136 | $3,487 | $4,283 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $17,108 | $18,449 | $20,498 | $22,595 | $25,116 | $27,284.7 | $29,674.5 |
| Gross Profit | $10,968 | $11,578 | $13,058 | $14,440 | $16,065 | - | - |
| EBITDA | $3,856 | $4,119 | $5,229 | $5,115 | $6,459 | - | - |
| Net Income | $1,994 | $2,358 | $3,165 | $2,993 | $3,246 | - | - |
| Diluted EPS | $5.21 | $6.17 | $8.25 | $7.76 | $8.40 | $15.02 | $16.75 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $2,944 | $1,844 | $2,971 | $3,652 | $4,011 |
| Short-term Debt | $7 | $1,191 | $2,094 | $1,409 | $1,000 |
| Long-term Debt | $12,472 | $11,857 | $10,901 | $12,188 | $14,859 |
| Total Debt | $12,479 | $13,048 | $12,995 | $13,597 | $15,859 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $3,263 | $2,624 | $3,711 | $4,242 | $5,044 |
| Capital Expenditure | $525 | $588 | $575 | $755 | $761 |
| Free Cash Flow | $2,738 | $2,036 | $3,136 | $3,487 | $4,283 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 19.2% | 7.8% | 11.1% | 10.2% | 11.2% |
| Gross Margin | 64.1% | 62.8% | 63.7% | 63.9% | 64.0% |
| EBITDA Margin | 22.5% | 22.3% | 25.5% | 22.6% | 25.7% |
| Net Margin | 11.7% | 12.8% | 15.4% | 13.2% | 12.9% |
| FCF Margin | 16.0% | 11.0% | 15.3% | 15.4% | 17.1% |
| Diluted EPS Growth | 24.0% | 18.4% | 33.7% | -5.9% | 8.2% |